Browsing by Author Wanner, Christoph

فهرست الفبایی 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 8 of 8
PreviewIssue DateTitleAuthor(s)
medicine article zn (5).pdf.jpg2013Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.de Zeeuw, Dick; Akizawa, Tadao; Audhya, Paul; Bakris, George L; Chin, Melanie; Christ-Schmidt, Heidi; Goldsberry, Angie; Houser, Mark; Krauth, Melissa; Lambers Heerspink, Hiddo J; McMurray, John J; Meyer, Colin J; Parving, Hans-Henrik; Remuzzi, Giuseppe; Toto, Robert D; Vaziri, Nosratola D; Wanner, Christoph; Wittes, Janet; Wrolstad, Danielle; Chertow, Glenn M
2019 EHJ Volume 40 Issue 11 March (1).pdf.jpg2019Cardiovascular outcome trials in patients with chronic kidney disease: Challenges associated with selection of patients and endpointsRossignol, Patrick; Agarwal, Rajiv; Canaud, Bernard; Charney, Alan; Chatellier, Gilles; Craig, Jonathan C.; Cushman, William C.; Gansevoort, Ronald T.; Fellström, Bengt; Garza, Dahlia; Guzman, Nicolas; Holtkamp, Frank a.; London, Gerard M.; Massy, Ziad a.; Mebazaa, Alexandre; Mol, Peter G.M.; Pfeffer, Marc a.; Rosenberg, Yves; Ruilope, Luis M.; Seltzer, Jonathan; Shah, Amil M.; Shah, Salim; Singh, Bhupinder; Stefánsson, Bergur V.; Stockbridge, Norman; Stough, Wendy Gattis; Thygesen, Kristian; Walsh, Michael; Wanner, Christoph; Warnock, David G.; Wilcox, Christopher S.; Wittes, Janet; Pitt, Bertram; Thompson, Aliza; Zannad, Faiez
2016 LANCET Volume 388 Issue 10041 July (7).pdf.jpg2016Dialysis 1 The heart and vascular system in dialysisWanner, Christoph; Amann, Kerstin; Shoji, Tetsuo
2018 EHJ Volume 39 Issue 5 February (5).pdf.jpg2018Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOMEVR trialFitchett, David; Butler, Javed; Van De Borne, Philippe; Zinman, Bernard; Lachin, John M.; Wanner, Christoph; Woerle, Hans J.; Hantel, Stefan; George, Jyothis T.; Johansen, Odd Erik; Inzucchi, Silvio E.
2018 Circulation Volume 137 Issue 2 January (4).pdf.jpg2018Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney diseaseWanner, Christoph; Lachin, John M.; Inzucchi, Silvio E.; Fitchett, David; Mattheus, Michaela; George, Jyothis; Woerle, Hans J.; Broedl, Uli C.; Von Eynatten, Maximilian; Zinman, Bernard
2016 NEJM Volume 375 Issue 18 November (4).pdf.jpg2016Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesWanner, Christoph; Inzucchi, Silvio E.; Lachin, John M.; Fitchett, David; von Eynatten, Maximilian; Mattheus, Michaela; Johansen, Odd Erik; Woerle, Hans J.; Broedl, Uli C.; Zinman, Bernard
2019 Circulation Volume 140 Issue 4 July (6).pdf.jpg2019Sodium Glucose Cotransporter 2 Inhibition and the Visualization of Kidney HemodynamicsWanner, Christoph
2018 EHJ Volume 39 Issue 20 May (11).pdf.jpg2018Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapyMüntze, Jonas; Salinger, Tim; Gensler, Daniel; Wanner, Christoph; Nordbeck, Peter